Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-14-052062
Filing Date
2014-07-17
Accepted
2014-07-17 17:29:41
Documents
6
Group Members
WINT2FELDEN HOLDING SA

Document Format Files

Seq Description Document Type Size
1 SC 13D a14-17346_3sc13d.htm SC 13D 89455
2 EX-99.1 a14-17346_3ex99d1.htm EX-99.1 62094
3 EX-99.2 a14-17346_3ex99d2.htm EX-99.2 28912
4 EX-99.3 a14-17346_3ex99d3.htm EX-99.3 34741
5 EX-99.4 a14-17346_3ex99d4.htm EX-99.4 34640
6 EX-99.5 a14-17346_3ex99d5.htm EX-99.5 194009
  Complete submission text file 0001104659-14-052062.txt   445141
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8444
Minerva Neurosciences, Inc. (Subject) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88240 | Film No.: 14981124
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address
Luthringer Remy (Filed by) CIK: 0001610384 (see all company filings)

Type: SC 13D